Lördag 22 November | 22:18:47 Europe / Stockholm

Kalender

Est. tid*
2025-11-14 - Kvartalsrapport 2025-Q3
2025-08-29 - Kvartalsrapport 2025-Q2
2025-05-14 - Kvartalsrapport 2025-Q1
2025-04-28 - X-dag ordinarie utdelning OMDA 0.00 NOK
2025-04-25 - Årsstämma
2025-02-26 - Bokslutskommuniké 2024
2024-11-25 - Extra Bolagsstämma 2024
2024-11-08 - Kvartalsrapport 2024-Q3
2024-08-23 - Kvartalsrapport 2024-Q2
2024-05-14 - Kvartalsrapport 2024-Q1
2024-04-29 - X-dag ordinarie utdelning OMDA 0.48 NOK
2024-04-25 - Årsstämma
2024-03-01 - Bokslutskommuniké 2023
2023-11-10 - Kvartalsrapport 2023-Q3
2023-09-26 - Extra Bolagsstämma 2023
2023-08-25 - Kvartalsrapport 2023-Q2
2023-05-12 - Kvartalsrapport 2023-Q1
2023-04-28 - X-dag ordinarie utdelning OMDA 0.00 NOK
2023-04-27 - Årsstämma
2023-02-28 - Bokslutskommuniké 2022
2022-11-30 - Kvartalsrapport 2022-Q3
2022-10-03 - Extra Bolagsstämma 2022
2022-08-30 - Kvartalsrapport 2022-Q2
2022-05-20 - X-dag ordinarie utdelning OMDA 0.00 NOK
2022-05-19 - Årsstämma
2022-05-19 - Kvartalsrapport 2022-Q1
2022-02-25 - Bokslutskommuniké 2021
2021-11-26 - Kvartalsrapport 2021-Q3
2021-08-31 - Kvartalsrapport 2021-Q2
2021-05-26 - Kvartalsrapport 2021-Q1
2021-05-07 - X-dag ordinarie utdelning OMDA 0.00 NOK
2021-05-06 - Årsstämma
2021-02-26 - Bokslutskommuniké 2020
2020-12-11 - Extra Bolagsstämma 2020
2020-11-27 - Kvartalsrapport 2020-Q3

Beskrivning

LandNorge
ListaEuronext Growth Oslo
SektorInformationsteknik
IndustriProgramvara
OMDA är verksamt inom teknikbranschen. Bolaget är specialiserat inom utveckling av digitala plattformar för vården. Programvaran är egenutvecklad och används huvudsakligen för analys och uppföljning av olika områden inom sjukvården. Utöver huvudverksamheten erbjuds även diverse mervärdestjänster. Verksamhet innehas på global nivå med störst närvaro inom den europeiska marknaden.

Intresserad av bolagets nyckeltal?

Analysera bolaget i Börsdata!

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

2025-11-14 07:00:00
Oslo, Norway, 14 November 2025 - Omda AS (Euronext Growth Oslo: OMDA)
today announced its financial results for the third quarter of 2025.

Reported revenue growth for the quarter was 14% compared with the same
period last year, with an EBITDA margin of 30%.

CEO Sverre Flatby commented: "Omda's strong first half was followed by
a record third quarter result."

The company has previously guided annual revenues of 460-485 MNOK
for 2025. With year-to-date revenues of 360 MNOK, Omda now expects
that full-year revenue to end toward the upper end of the guided range.
The EBITDA margin guidance of 23-27% for the year is maintained.

"This quarter further strengthens the foundation for our public guidance
for both 2025 and 2026," Flatby added.
Omda has previously communicated guidance for 2026 of 500-525 MNOK
in revenue and an expected EBITDA margin of 28-32%.

"Our profitable, market-leading portfolio of niche solutions within
specialised healthcare and emergency services has been built through a
series of acquisitions. Our current M&A pipeline indicates that 10-20%
inorganic growth will be added on top of the guided 2026 revenues,"
Flatby concluded.

Highlights from the report:

- EBITDA margin of 30%
- Reported growth of 14% vs. Q3-24
- Organic growth of 7% vs. Q3-24
- ARR up 15% vs. Q3-24
- Working capital 8 percentage points better than in Q3-24

For more information, please contact:
Einar Bonnevie
Chief Financial Officer
+47 91 55 45 32
einar.bonnevie@omda.com

About Omda
Omda is the leading provider of niche software for specialised healthcare
and emergency services in the Nordics with a growing presence in Europe,
North America and the Pacific region. The company has more than 750
contracts in 25 countries and employs approximately 260 dedicated
specialists. Our highly specialised healthcare solutions empower medical
professionals and emergency responders, enabling them to know more and
work smarter. With a focus on user-centric design, value-driven development
and close working relationships with customers, Omda delivers solutions
that enhance patient safety and improve healthcare outcomes.

For more information, visit www.omda.com
Follow us on LinkedIn
Subscribe to our newsletter: http://eepurl.com/dsoOJH